Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2023 Earnings and Company Updates

<p>CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, will present its second quarter 2023 financial results and operational highlights in a conference call on August 3, 2023, at 8 a.m. ET. To join the call: U.S. […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/intellia-therapeutics-to-hold-conference-call-to-discuss-second-quarter-2023-earnings-and-company-updates/">Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2023 Earnings and Company Updates</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>